SNDL Inc. (SNDL) is One Cannabis Stock Investors Should Not Ignore
As of April 15 closing, consensus sentiment around SNDL Inc. (NASDAQ:SNDL) was moderately bullish. The stock received 2 Buy ratings and carries a median 1-year target price of $4.75.
Here’s why the Tilray Brands stock may surge soon despite major risks
Setup: falling wedge + small inverted H&S with price below key support ($7) and far under 50/100-day EMAs; earnings show record revenue ($206.7M), double-digit growth, improving margins (wellness …
TSX Penny Stocks: 3 Picks With Market Caps Over CA$6M
Despite recent inflationary pressures and concerns about consumer confidence, the Canadian S&P/TSX index has shown resilience, climbing 7.5% from its mid-March low. In such a fluctuating market, penny …
Tilray Posted Record Numbers Last Quarter, but Where the Bulk of Its Growth Has Come From Over the Past 4 Years Might Surprise You
Tilray Brands (NASDAQ: TLRY) is a leading cannabis company based in Canada. However, despite leading the industry, intense competition in the domestic market has made it exceeding …
245% Upside Potential for Sundial Growers (SNDL) After 18% YTD Slide
SNDL Inc. (NASDAQ:SNDL) currently trades at $1.36, while the average analyst price target sits at $4.70, implying an upside of roughly 245% from current levels. SNDL is Canada’s largest private-sector …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
The cannabis rescheduling is causing celebration — and confusion — as marijuana stocks sell off
Marijuana stocks sold off Thursday, after acting U.S. Attorney General Todd Blanche signed an order rescheduling FDA-approved and state-licensed medical cannabis products as a less harmful substance — a move that led to celebration but also confusion among industry...
Cannabis Stocks Soared—Than Sank. Here’s What Investors Need to Know.
Cannabis stocks and funds that hold them surged after the Trump administration moved it from the government most restrictive drug category to one that can be obtainable with a prescription.
Cannabis Stocks Jump After U.S. Reclassifies Marijuana as Less Dangerous Drug
Shares of cannabis companies rose after the Trump administration reclassified marijuana as a less dangerous drug. Curaleaf increased 5.8% in premarket trading after surging 26% Wednesday on a report …
Tilray and other pot stocks soar as Trump is reportedly ready to reclassify cannabis
The move, which could open up medical research on cannabis as well as banking services for growers, follows an executive order to reclassify the substance in December.
Canadians could claim part of $8-million cannabis settlement
Canadians who invested in cannabis stock could cash in on a hefty class-action settlement against Wayland Group Corp.
Cannabis stocks on track for best week of 2026 as FDA loosens CBD enforcement
Tilray Brands, Canopy Growth, and Curaleaf Holdings stocks are surging after the FDA says it won’t enforce some regulations for CBD products.
Tilray Brands’ strong cannabis sales and upbeat outlook keeps Jefferies analysts bullish
Tilray Inc (NASDAQ:TLRY) earned a repeat ‘Buy’ rating from Jefferies analysts after what it described as a solid third quarter earnings report, pointing to improving fundamentals and increased …
Cambria Cannabis ETF Closes Up Shop as Investor Interest Fades
A cannabis ETF has come down from its high. Cambria Investment Management recently announced its Cambria Cannabis ETF (TOKE) is closing up shop. Shareholders have until April 17 to sell their holdings …
Oppenheimer Lowers Chicago Atlantic Real Estate Finance, Inc. (REFI) from Outperform to Perform
Chicago Atlantic Real Estate Finance, Inc. (NASDAQ:REFI) is one of the 11 Best Marijuana Stocks to Buy Right Now. On March 16, 2026, Oppenheimer lowered Chicago Atlantic Real Estate Finance, Inc.
Recent Comments